Results 181 to 190 of about 51,637 (256)

Identifying Red Flags in Myasthenia Gravis Diagnosis, Reassessment, and Myasthenic Crisis: An Italian Delphi‐Based Position Paper

Acta Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background and Purpose Myasthenia gravis (MG) is a complex autoimmune disorder affecting neuromuscular transmission, often leading to diagnostic and therapeutic challenges. Timely identification of “red flags” in diagnosis, therapeutic reassessment, and myasthenic crisis is crucial to optimizing patient outcomes. This Delphi‐based consensus is aimed at
Francesco Habetswallner, Luca Bello, Fiammetta Biasini, Bernardo Maria De Martino, Fiammetta Vanoli, Paolo E. Alboini, Giovanni Antonini, Carlo Antozzi, Valentina Damato, Vincenzo Di Stefano, Amelia Evoli, Matteo Gastaldi, Raffaele Iorio, Michelangelo Maestri, Renato Mantegazza, Roberto Massa, Rita Rinaldi, Francesco Saccà, Carmelo Rodolico, Dominic B. Fee   +19 more
wiley   +1 more source

Myasthenia gravis and community-acquired pneumonia: therapeutic challenges. [PDF]

Front Pharmacol
Chen X, Ding J, Zhang J, Dai H, Yu L.
europepmc   +1 more source

FK506 attenuates thymic output in patients with myasthenia gravis [PDF]

, 2013
Takao Mitsui, Yukiko Kuroda, Shuichi Ueno, Naoko Matsui, Ryuji Kaji   +4 more
openalex   +1 more source

Autosplenectomy in a Patient With Autoimmune Polyglandular Syndrome Type 2 (APS‐2)

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Autoimmune glandular syndrome type 2 is a complex genetic condition where a triad of endocrinopathies is involved, namely, Addison’s disease, type 1 diabetes, and/or autoimmune thyroid disorder. The disease predisposes one to a variety of other autoimmune associations.
Luqman S. Fauzi, Airin Jyoty, Yashwin Sredharan, Manohara Kenchaiah, Osamu Isozaki   +4 more
wiley   +1 more source

Risk factors for generalization of ocular myasthenia gravis. [PDF]

Indian J Ophthalmol
Djordjevic IS, Peric S, Djordjevic SA, Lavrnic D, Marasevic K, Apostolski S, Kosac A, Basta I.   +7 more
europepmc   +1 more source

Über enen Fall von Myasthenia gravis pseudoparalytica, bei welchem durch Schilddrüsenmittel und Nebennierenpulver Besserung erzielt wurde

, 1939
S. Inui, H. Morikawa
openalex   +2 more sources

Coincidence of myasthenia gravis and antiglomerular basement membrane glomerulonephritis: a combination of two antibody-mediated autoimmune diseases on day 15 [PDF]

, 1997
S. Drube, N. Maurin, H. G. Sieberth
openalex   +1 more source

Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experience. [PDF]

BMJ Neurol Open
Roddate M, Žukova V, Grosmane A, Ķauķe G, Glāzere I, Punga AR, Ķēniņa V.   +6 more
europepmc   +1 more source

A case of myasthenia gravis with coexistence of anti-acetylcholine receptor antibodies and anti-P/Q-type VGCC antibodies

Yuki Takeda, Yoshikatsu Noda, Naohiko Seike, Hiroyuki Ishihara   +3 more
openalex   +2 more sources

Nipocalimab Dose Selection in Generalized Myasthenia Gravis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Valenzuela B, Neyens M, Zhu Y, Ramchandren S, Dosne AG, Leu JH, Faelens R, Ling LE, Pérez-Ruixo JJ.   +8 more
europepmc   +1 more source